Vistin Pharma ASA: Invitation To Q4 2024 Conference Call

2025-02-06 05:01:21

(MENAFN- GlobeNewsWire - Nasdaq) Oslo, Norway, 6 February 2025

Vistin Pharma ASA will release its fourth quarter and preliminary 2024 results on Thursday 13th of February 2025. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day at 08:30 CET. There will be a Q&A session following the management discussion.

The conference call will be held in English.

The fourth quarter conference call will be available via web and audio through the following access points:

Webcast:

Telephone conference (online registration):

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
...

About Vistin Pharma |

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

MENAFN06022025004107003653ID1109175283

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.